التفاصيل البيبلوغرافية
| العنوان: |
COVID-19 Infection in Ultramarathon Runners: Findings of the Ultrarunners Longitudinal TRAcking Study. |
| المؤلفون: |
Jastifer, James R.1,2 jrjast@gmail.com, Jastifer, Ethan J.1, Hoffman, Martin D.1 |
| المصدر: |
Clinical Journal of Sport Medicine. Nov2024, Vol. 34 Issue 6, p597-602. 6p. |
| مصطلحات موضوعية: |
*RESPIRATORY organ sounds, *LONG-distance running, *CHEST pain, *HOSPITAL care, *FATIGUE (Physiology), *PHARYNGITIS, *POST-acute COVID-19 syndrome, *FEVER, *SEVERITY of illness index, *EXTREME sports, *ATHLETES, *SURVEYS, *RHINORRHEA, *ATHLETIC ability, *LENGTH of stay in hospitals, *COUGH, *DYSPNEA, *TACHYCARDIA, *COVID-19 |
| مستخلص: |
Objective: Ultramarathon runners are a unique patient population who have been shown to have a lower rate of severe chronic medical conditions. This study aimed to determine the effect that COVID-19 infection has had on this population and their running behavior. Design: The Ultrarunners Longitudinal TRAcking (ULTRA) Study is a large longitudinal study of ultramarathon runners. Questions on health status, running behavior, and COVID-19 infection were included in the most recent survey. Setting: Community survey. Participants: Seven hundred thirty-four ultramarathon runners participated in the study. Interventions: None. Main Outcome Measures: Personal, exercise, and COVID-19 infection history. Results: 52.7% of study participants reported having been symptomatic from a COVID-19 infection, with 6.7% testing positive multiple times. Participants required a total of 4 days of hospitalization. The most common symptoms included fever (73.6%), fatigue (68.5%), sore throat (68.2%), runny nose (67.7%), and cough (67.4%). Cardiovascular symptoms, which are of particular interest in the running population, included shortness of breath (46.3%), tachycardia (44.7%), chest pain (36.2%), and wheezing (33.3%). A total of 50 subjects (6.8%) reported long COVID (symptoms lasting more than 12 weeks). Conclusions: Severe COVID-19 infection has been rare in this population of ultramarathon runners, although symptomatic infection that affects running is common. To support the well-being of this group of highly active athletes, clinicians should appreciate that cardiovascular symptoms are common and the long-term significance of these symptoms in runners is unknown. Level of Evidence: Level 2 prospective study. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |